MPLT
MapLight Therapeutics, Inc. · Healthcare
Chief Discovery Officer Anatol Kreitzer sold $1.3M of MapLight Therapeutics, Inc.
Sold$1,345,894
$37.09Price
36,284Shares
−17%Stake
What MPLT did after the filing
- The stock from Mon, Jul 20 open, $38.11
- −65.1%
- S&P 500, same days
- +2.0%
Measured over 30 trading days, to the Sep 1 close.
Traded Wed, Jul 15. Filed Mon, Jul 20, 6:00 AM ET, before the open. Returns use the Jul 20 open and the Sep 1 close. Not investment advice.